Accuray Incorporated (0H8I.L)
USD 1.91
(-2.54%)
USD 1.91
(-2.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 468.62 Million USD | -2.21% |
| 2022 | 479.21 Million USD | 1.35% |
| 2021 | 472.84 Million USD | -1.51% |
| 2020 | 480.09 Million USD | -2.21% |
| 2019 | 490.92 Million USD | 12.04% |
| 2018 | 438.18 Million USD | 15.7% |
| 2017 | 378.72 Million USD | -6.82% |
| 2016 | 406.46 Million USD | -13.34% |
| 2015 | 469.03 Million USD | 0.48% |
| 2014 | 466.77 Million USD | -5.74% |
| 2013 | 495.18 Million USD | 4.05% |
| 2012 | 475.92 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 468.62 Million USD | -2.21% |
| 2023 Q1 | 476.83 Million USD | -0.5% |
| 2023 Q2 | 476.35 Million USD | -0.1% |
| 2023 Q3 | 462.52 Million USD | -2.9% |
| 2023 Q4 | 468.62 Million USD | 1.32% |
| 2022 Q3 | 475.72 Million USD | 1.48% |
| 2022 Q4 | 479.21 Million USD | 0.73% |
| 2022 Q1 | 466.34 Million USD | -1.37% |
| 2022 Q2 | 468.76 Million USD | 0.52% |
| 2022 FY | 479.21 Million USD | 1.35% |
| 2021 Q3 | 469.43 Million USD | -1.28% |
| 2021 FY | 472.84 Million USD | -1.51% |
| 2021 Q1 | 475.77 Million USD | -0.9% |
| 2021 Q2 | 475.5 Million USD | -0.06% |
| 2021 Q4 | 472.84 Million USD | 0.73% |
| 2020 Q4 | 480.09 Million USD | -1.38% |
| 2020 Q2 | 478.14 Million USD | 2.89% |
| 2020 Q1 | 464.71 Million USD | -5.34% |
| 2020 Q3 | 486.82 Million USD | 1.82% |
| 2020 FY | 480.09 Million USD | -2.21% |
| 2019 Q2 | 479.47 Million USD | 3.39% |
| 2019 FY | 490.92 Million USD | 12.04% |
| 2019 Q4 | 490.92 Million USD | 0.19% |
| 2019 Q3 | 489.98 Million USD | 2.19% |
| 2019 Q1 | 463.74 Million USD | 5.83% |
| 2018 Q2 | 386.07 Million USD | 4.59% |
| 2018 Q1 | 369.13 Million USD | -2.53% |
| 2018 FY | 438.18 Million USD | 15.7% |
| 2018 Q4 | 438.18 Million USD | 7.89% |
| 2018 Q3 | 406.13 Million USD | 5.2% |
| 2017 Q1 | 393.95 Million USD | -3.08% |
| 2017 Q4 | 378.72 Million USD | -2.22% |
| 2017 FY | 378.72 Million USD | -6.82% |
| 2017 Q3 | 387.31 Million USD | -6.43% |
| 2017 Q2 | 413.93 Million USD | 5.07% |
| 2016 Q1 | 422.73 Million USD | -9.87% |
| 2016 Q4 | 406.46 Million USD | -2.49% |
| 2016 FY | 406.46 Million USD | -13.34% |
| 2016 Q3 | 416.84 Million USD | 0.41% |
| 2016 Q2 | 415.16 Million USD | -1.79% |
| 2015 FY | 469.03 Million USD | 0.48% |
| 2015 Q4 | 469.03 Million USD | -4.28% |
| 2015 Q3 | 490.02 Million USD | 3.53% |
| 2015 Q2 | 473.32 Million USD | 2.5% |
| 2015 Q1 | 461.8 Million USD | -1.06% |
| 2014 Q1 | 459.63 Million USD | -7.18% |
| 2014 Q2 | 467.56 Million USD | 1.72% |
| 2014 Q4 | 466.77 Million USD | 0.67% |
| 2014 Q3 | 463.65 Million USD | -0.84% |
| 2014 FY | 466.77 Million USD | -5.74% |
| 2013 Q2 | 485.2 Million USD | 2.55% |
| 2013 Q3 | 491.07 Million USD | 1.21% |
| 2013 Q4 | 495.18 Million USD | 0.84% |
| 2013 FY | 495.18 Million USD | 4.05% |
| 2013 Q1 | 473.16 Million USD | -0.58% |
| 2012 Q4 | 475.92 Million USD | -4.25% |
| 2012 FY | 475.92 Million USD | 0.0% |
| 2012 Q2 | 415.63 Million USD | 0.0% |
| 2012 Q3 | 497.07 Million USD | 19.59% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -26.286% |
| Align Technology, Inc. | 6.08 Billion USD | 92.297% |
| Elevance Health Inc. | 108.92 Billion USD | 99.57% |
| AxoGen, Inc. | 196.82 Million USD | -138.091% |
| Boston Scientific Corporation | 35.13 Billion USD | 98.666% |
| CVS Health Corporation | 249.72 Billion USD | 99.812% |
| Cardinal Health, Inc. | 45.12 Billion USD | 98.961% |
| Centene Corporation | 84.64 Billion USD | 99.446% |
| DaVita Inc. | 17.61 Billion USD | 97.34% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 99.166% |
| Hologic, Inc. | 9.15 Billion USD | 94.882% |
| Humana Inc. | 47.06 Billion USD | 99.004% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 85.625% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 97.198% |
| Masimo Corporation | 3.04 Billion USD | 84.592% |
| McKesson Corporation | 67.44 Billion USD | 99.305% |
| Patterson Companies, Inc. | 2.96 Billion USD | 84.216% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 96.658% |
| ResMed Inc. | 6.87 Billion USD | 93.181% |
| Henry Schein, Inc. | 10.57 Billion USD | 95.568% |
| Teladoc Health, Inc. | 4.39 Billion USD | 89.331% |
| Universal Health Services, Inc. | 14.35 Billion USD | 96.736% |
| Veeva Systems Inc. | 5.91 Billion USD | 92.072% |
| Baxter International Inc. | 28.27 Billion USD | 98.343% |
| Becton, Dickinson and Company | 52.78 Billion USD | 99.112% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 96.965% |
| Danaher Corporation | 84.48 Billion USD | 99.445% |
| Stryker Corporation | 39.91 Billion USD | 98.826% |
| Medtronic plc | 89.98 Billion USD | 99.479% |